Notice of Intent to Sole Source: Surveillance based Lyme Disease Network

Closed Special Notice Posted

Solicitation number
75D30124R72992
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Danville, Pennsylvania, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) has issued a Special Notice indicating their intent to award a sole source firm fixed price purchase order to Geisinger Clinic for the Surveillance Based Lyme Disease Network. This is a follow-on contract to continue the services Geisinger Clinic has been providing under the current contract.

The purpose of this Special Notice is to inform interested parties that the CDC has determined Geisinger Clinic is the only responsible source that can satisfy the agency's requirements to develop, finalize, and implement Electronic Health Record (EHR) algorithms for estimating Lyme Disease (LD) incidence and outcomes, as well as monitor LD epidemiology trends. The significant start-up efforts, experience, and knowledge sharing required have already been established under the current contract. Interested parties may submit responses by 12:00 PM EST on May 29, 2024, but this is not a request for competitive quotes, and the CDC has sole discretion in determining whether to compete the proposed contract.

Notice text

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to Geisinger Clinic for Surveillance Based Lyme Disease Network as a follow-on contract to 75D30123C18193. Geisinger is required to provide continued services to develop, finalize, and implement Electronic Health Record (HER) algorithms to provide estimates of Lyme Disease (LD) incidence and LD outcomes, and to monitor trends in LD epidemiology. Only one responsible source and no other services will satisfy agency requirements, as the start-up efforts, in terms of time, experience, and knowledge sharing, for all network participants have been significant and any contract awarded to other vendors would result in a loss of work and current data already collected. We therefore conclude that the only vendor option for the service contract is Geisinger Clinic. This contract action is for services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 6.302-1. Interested persons may identify their interest and capability to respond to the requirement or submit proposals.

This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government.  A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government.  Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.  Any quotation/response should be emailed to contract specialist at msipin@cdc.gov by 12:00 PM EST on 29 May 2024.

Files

File Type Posted
JA_Geisinger Final 14 May 2024.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity